A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC
Status:
Terminated
Trial end date:
2020-12-08
Target enrollment:
Participant gender:
Summary
The aim of this trial is to study the tolerance, pharmacokinetics (PK) and efficacy of
SHR2554 alone or in combination with SHR3680 in the treatment of patients with metastatic
Castration Resistant Prostate Cancer.